Results 211 to 220 of about 432,090 (383)
What's New? PARP inhibitors are effective in patients with inactivating alterations in the BRCA1/2 genes across tumor types. However, the efficacy of PARP inhibitors in patients with other inactivated homologous recombination repair genes remains unclear. This knowledge gap and discrepancies in EMA/FDA approvals highlight the need for better biomarkers.
Ilse A. C. Spiekman +15 more
wiley +1 more source
What's New? Anti‐angiogenic drugs have shown promising efficacy as a second‐line treatment for advanced gastric cancer. However, it remains unclear how alterations in the tumor microenvironment following first‐line immunotherapy may impact tumor angiogenesis and influence subsequent therapeutic outcomes. This single‐arm study prospectively explored the
Xiaoting Ma +11 more
wiley +1 more source
Prenatal vitamin D levels and postpartum hemorrhage in a rural Alaska cohort
Abstract Objective To examine the relationship between prenatal vitamin D serum levels and postpartum bleeding. Methods We conducted a retrospective electronic health record cohort study of pregnant Alaska Native and American Indian (ANAI) people in southwestern Alaska who had at least one prenatal vitamin D level measurement recorded and had a vaginal
Reinou S. Groen +7 more
wiley +1 more source
Abstract Objective To determine delivery outcomes in women diagnosed with prelabor rupture of membranes (PROM) who required re‐amniotomy. Methods This retrospective cohort study included 24 966 women with PROM at a single university‐affiliated tertiary medical center (2011–2023).
Roza Berkovitz‐Shperling +4 more
wiley +1 more source
Viper (Agkistrodon halys blomhoffii "Mamushi") Bite with Remarkable Thrombocytopenia
Motoki Fujita +6 more
openalex +2 more sources
Cytokine-Mediated Disruption of Lymphocyte Trafficking, Hemopoiesis, and Induction of Lymphopenia, Anemia, and Thrombocytopenia in Anti-CD137-Treated Mice [PDF]
Liguo Niu +11 more
openalex +1 more source
Abstract Objective To assess the prevalence of hemostasis abnormalities at the time of fetal death diagnosis. Methods This retrospective single‐center study included all fetal deaths between 22 and 42 weeks from July 2017 to December 2023, excluding multiple pregnancies, patients on anticoagulant therapy, and those with known pre‐existing coagulation ...
Chloé Lieng +2 more
wiley +1 more source
The impact of platelet transfusion characteristics on posttransfusion platelet increments and clinical bleeding in patients with hypoproliferative thrombocytopenia [PDF]
Darrell J. Triulzi +7 more
openalex +1 more source
First Report of Eltrombopag Induced Severe Autoimmune Hemolytic Anemia in the Management of Waldenström Macroglobulinemia-associated Autoimmune Thrombocytopenia [PDF]
Yingying Shen +7 more
openalex +1 more source

